Overcoming Multidrug Resistance by Reversan and Exterminating Glioblastoma and Glioblastoma Stem Cells by Delivering Drug-Loaded Nanostructure Hybrid Lipid Capsules (nHLCs)

Investigators targeted P-glycoprotein using a small molecule inhibitor, reversan, to inhibit multidrug resistance that prolonged the retention of drugs in the cytosolic milieu.